DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Our mission is to improve the lives of those suffering from the debilitating effects of degenerative diseases of the spine.
DiscGenics is led by a veteran team of medical device and biologics industry executives, practicing clinicians and successful innovators in the orthopedics, spinal and neurosurgical markets.
Executive Team & Board of Directors
Flagg Flanagan - Chief Executive Officer & Chairman of the Board
Mr. Flanagan has over 30 years of experience in the medical device field as an entrepreneur, executive and advisor. He founded Flanagan Instruments in 1981, which he built into a leading neurosurgical device distribution business before selling it to Itochu International in 2005. Mr. Flanagan is currently on the boards of the Alliance for Regenerative Medicine, the Neurosurgery Research & Education Foundation and TrueVision Systems. He has also served on the board of Image Stream Medical, which was acquired by Olympus in 2017. He completed the Owner/President Management Program at Harvard Business School.
Bob Wynalek - Chief Operating & Commercialization Officer, Director
Mr. Wynalek is a skilled medical device and biologics executive with over 30 years of experience in the orthopedic, spinal and neurosurgical markets. Most recently, Mr. Wynalek was the President of domestic business for Osteotech, Inc. where he oversaw development, regulatory clearance and commercialization of numerous biologic devices for bone healing. Osteotech, Inc. was acquired by Medtronic, Inc. in 2010. Mr. Wynalek currently serves as a committee member of the Alliance for Regenerative Medicine and BioUtah.
Kevin T. Foley, M.D. - Chief Medical Officer, Director
Dr. Foley is a practicing neurosurgeon and active entrepreneur who invented many of the surgical devices and techniques that have revolutionized minimally invasive spine surgery. Dr. Foley is the Chairman of Semmes-Murphy Neurologic & Spine Institute and a tenured professor of neurosurgery, orthopedic surgery and biomedical engineering at the University of Tennessee. He has authored over 35 book chapters and more than 125 journal publications, lectured at more than 600 scientific meetings and educational workshops, and holds more than 150 patents issued by the USPTO. Dr. Foley is the recipient of the 2019 AANS Cushing Award for Technical Excellence and Innovation in Neurosurgery, awarded by the American Association of Neurological Surgeons. He received his M.D. from UCLA.
DiscGenics is proud to be a member of the following industry organizations:
At DiscGenics, we are a small, highly focused team that prides ourselves on our ability to act nimbly and efficiently to pioneer cutting edge therapies on behalf of our patients and investors.
We are looking for motivated individuals to join our team who share our passion for improving the lives of others.